Adicet Bio Inc. (ACET)
Adicet Bio Statistics
Share Statistics
Adicet Bio has 82.69M shares outstanding. The number of shares has increased by 0.62% in one year.
| Shares Outstanding | 82.69M |
| Shares Change (YoY) | 0.62% |
| Shares Change (QoQ) | 0.35% |
| Owned by Institutions (%) | 63.35% |
| Shares Floating | 65.36M |
| Failed to Deliver (FTD) Shares | 409 |
| FTD / Avg. Volume | 0.05% |
Short Selling Information
The latest short interest is 3.43M, so 4.16% of the outstanding shares have been sold short.
| Short Interest | 3.43M |
| Short % of Shares Out | 4.16% |
| Short % of Float | 5.18% |
| Short Ratio (days to cover) | 7.04 |
Valuation Ratios
The PE ratio is -0.72 and the forward PE ratio is -0.69. Adicet Bio's PEG ratio is 0.01.
| PE Ratio | -0.72 |
| Forward PE | -0.69 |
| PS Ratio | 0 |
| Forward PS | null |
| PB Ratio | 0.45 |
| P/FCF Ratio | -0.9 |
| PEG Ratio | 0.01 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Adicet Bio.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.29, with a Debt / Equity ratio of 0.09.
| Current Ratio | 9.29 |
| Quick Ratio | 9.29 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | -0.14 |
| Debt / FCF | -0.18 |
| Interest Coverage | 31903.75 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $0 |
| Profits Per Employee | $-770.54K |
| Employee Count | 152 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -67.7% in the last 52 weeks. The beta is 1.62, so Adicet Bio's price volatility has been higher than the market average.
| Beta | 1.62 |
| 52-Week Price Change | -67.7% |
| 50-Day Moving Average | 0.87 |
| 200-Day Moving Average | 1.17 |
| Relative Strength Index (RSI) | 37.28 |
| Average Volume (20 Days) | 797.39K |
Income Statement
| Revenue | n/a |
| Gross Profit | 0 |
| Operating Income | -127.61M |
| Net Income | -117.12M |
| EBITDA | -127.61M |
| EBIT | -117.13M |
| Earnings Per Share (EPS) | -1.33 |
Balance Sheet
The company has 56.49M in cash and 17.23M in debt, giving a net cash position of 39.26M.
| Cash & Cash Equivalents | 56.49M |
| Total Debt | 17.23M |
| Net Cash | 39.26M |
| Retained Earnings | -497.89M |
| Total Assets | 220.22M |
| Working Capital | 160.74M |
Cash Flow
In the last 12 months, operating cash flow was -92.38M and capital expenditures -1.12M, giving a free cash flow of -93.5M.
| Operating Cash Flow | -92.38M |
| Capital Expenditures | -1.12M |
| Free Cash Flow | -93.5M |
| FCF Per Share | -1.06 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ACET pays an annual dividend of $0.15, which amounts to a dividend yield of 0.14%.
| Dividend Per Share | $0.15 |
| Dividend Yield | 0.14% |
| Dividend Growth (YoY) | 0% |
| Payout Ratio | -11.28% |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for ACET is $6, which is 721.9% higher than the current price. The consensus rating is "Buy".
| Price Target | $6 |
| Price Target Difference | 721.9% |
| Analyst Consensus | Buy |
| Analyst Count | 7 |
Stock Splits
The last stock split was on Sep 16, 2020. It was a backward split with a ratio of 1:7.
| Last Split Date | Sep 16, 2020 |
| Split Type | backward |
| Split Ratio | 1:7 |
Scores
| Altman Z-Score | -2.96 |
| Piotroski F-Score | 2 |